Zobrazeno 1 - 10
of 13
pro vyhledávání: '"G. V. Ilyinskaya"'
Autor:
K. V. Sivak, K. I. Stosman, E. Yu. Kalinina, M. M. Lyubishin, Ya. R. Orshanskaya, T. N. Savateeva-Lyubimova, S. B. Kazakova, D. M. Fedoseeva, A. S. Nazarov, E. I. Radion, S. M. Yudin, A. A. Keskinov, V. V. Makarov, V. S. Yudin, A. O. Zheltukhin, P. O. Vorobyev, D. V. Kochetkov, G. V. Ilyinskaya, A. V. Lipatova, P. M. Chumakov
Publikováno v:
Безопасность и риск фармакотерапии, Vol 0, Iss 0 (2022)
INTRODUCTION. Developing novel medicines based on non-pathogenic enterovirus strains exhibiting oncotropic and oncolytic properties represents an up-to-date and safe approach to complex cancer treatment and postoperative metastasis prevention. Safety
Externí odkaz:
https://doaj.org/article/c3aafa14645e435fa0f9881cad8c8c77
Publikováno v:
Biomedical and Pharmacology Journal. 11:759-767
In mammals a small family of genes called Sestrins play important roles in the maintenance of metabolic and redox homeostasis, suggesting that the genes may positively affect the lifespan and counteract the age-related functional decline. The nematod
Publikováno v:
Molecular Biology. 52:306-322
Publikováno v:
Молекулярная биология. :360-379
Preclinical studies demonstrate that a broad spectrum of human and animal malignant cells can be killed by oncolytic paramyxoviruses, which includes cells of ecto-, endo- and mesodermal origin. In clinical trials, significant reduction or even comple
Publikováno v:
Molekuliarnaia biologiia. 52(3)
Preclinical studies demonstrate that a broad spectrum of human and animal malignant cells can be killed by oncolytic paramyxoviruses, which includes cells of ecto-, endo- and mesodermal origin. In clinical trials, significant reduction or even comple
Autor:
V. S. Prasolov, Julia E. Kravchenko, P. M. Chumakov, G. V. Ilyinskaya, S. P. Chumakov, Elena I. Frolova
Publikováno v:
Molecular Biology. 42:894-900
An enzymatic assay system was developed to quantify the distribution of recombinant proteins over various cell structures. The system takes advantage of α-complementation of β-galactosidase. The large ω fragment of β-galactosidase is expressed in
Autor:
Andrei V. Budanov, G. V. Ilyinskaya, P. M. Chumakov, D. V. Kochetkov, P. G. Komarov, Alexey V. Ivanov, L. S. Agapova, E. Strom, Elena I. Frolova
Publikováno v:
Molecular Biology. 41:459-466
Inactivation of tumor suppressor p53 accompanies the majority of human malignancies. Restoration of p53 function causes death of tumor cells and is potentially suitable for gene therapy of cancer. In cervical carcinoma, human papilloma virus (HPV) E6
Autor:
L. S. Agapova, G. V. Ilyinskaya, Peter M. Chumakov, Nikolai A. Turovets, Boris P. Kopnin, Alexey V. Ivanov
Publikováno v:
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 354:129-138
It has been proposed that p53 tumor-suppressor plays a key role in maintaining genome integrity in mammalian cells. We analyzed karyotype alterations in human and murine cell sublines expressing various exogenous human mutant (His175, Trp248, His273)
Autor:
Anton V. Gorbachev, Danielle D. Kish, Marianne Petro, Robert L. Fairchild, Anna A. Kondratova, Olga A. Guryanova, G. V. Ilyinskaya
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 190(2)
During growth in the host, tumor cells are subjected to the stresses of innate and adaptive immunity (immunoediting), which provoke epigenetic changes in the tumor and increase tumor resistance to these immune responses. Our recent studies in methylc
Autor:
D. V. Kochetkov, Evguenia Strom, Julia E. Kravchenko, Andrei V. Gudkov, Elena I. Frolova, Elena Feinstein, P. M. Chumakov, I. Kovriga, Pavel G. Komarov, G. V. Ilyinskaya, L. S. Agapova
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America. 105(17)
Identification of unique features of cancer cells is important for defining specific and efficient therapeutic targets. Mutant p53 is present in nearly half of all cancer cases, forming a promising target for pharmacological reactivation. In addition